Validation of quantitative susceptibility mapping with Perls' iron staining for subcortical gray matter

NeuroImage

Volumn 105, Issue , 2015, Pages 486-492

  Sun, Hongfu ^a   Walsh, Andrew J ^a   Lebel, R Marc ^a   Blevins, Gregg ^a   Catz, Ingrid ^a   Lu, Jian Qiang ^a   Johnson, Edward S ^a   Emery, Derek J ^a   Warren, Kenneth G ^a   Wilman, Alan H ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Brain iron; Perls' iron stain; Postmortem imaging; Quantitative susceptibility mapping; R2* mapping; Subcortical gray matter

Indexed keywords

IRON;

ADULT; ARTICLE; BRAIN MAPPING; BRAIN SLICE; CASE REPORT; CONTROLLED STUDY; GRAY MATTER; HISTOCHEMISTRY; HUMAN; HUMAN TISSUE; IMAGE RECONSTRUCTION; IN VIVO STUDY; INTERMETHOD COMPARISON; MALE; MEASUREMENT ACCURACY; MIDDLE AGED; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PERL FERRIC IRON STAINING; QUANTITATIVE SUSCEPTIBILITY MAPPING; STAINING; SUBCORTEX; VALIDATION STUDY; BRAIN CHEMISTRY; CHEMISTRY; MAGNETISM; METABOLISM; PATHOLOGY; PROCEDURES;

BRAIN CHEMISTRY; GRAY MATTER; HUMANS; IRON; MAGNETIC PHENOMENA; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS;

EID: 84914819968     PISSN: 10538119     EISSN: 10959572     Source Type: Journal    
DOI: 10.1016/j.neuroimage.2014.11.010     Document Type: Article

References (54)

1. Al-Alousi L.M., Anderson R.A., Worster D.M., Land D.V. Multiple-probe thermography for estimating the postmortem interval: II. Practical versions of the Triple-Exponential Formulae (TEF) for estimating the time of death in the field. J. Forensic Sci. 2001, 46:323-327.
2. Aquino D., Bizzi A., Grisoli M., Garavaglia B., Bruzzone M.G., Nardocci N., Savoiardo M., Chiapparini L. Age-related iron deposition in the basal ganglia: quantitative analysis in healthy subjects. Radiology 2009, 252:165-172. 10.1148/radiol.2522081399.
3. Berg D., Youdim M.B.H. Role of iron in neurodegenerative disorders. Top. Magn. Reson. Imaging 2006, 17:5-17. 10.1097/01.rmr.0000245461.90406.ad.
4. Bilgic B., Pfefferbaum A., Rohlfing T., Sullivan E.V., Adalsteinsson E. MRI estimates of brain iron concentration in normal aging using quantitative susceptibility mapping. Neuroimage 2012, 59:2625-2635. 10.1016/j.neuroimage.2011.08.077.
5. Birkl C., Langkammer C., Krenn H., Goessler W., Ernst C., Haybaeck J., Stollberger R., Fazekas F., Ropele S. Iron mapping using the temperature dependency of the magnetic susceptibility. Magn. Reson. Med. 2014, 00:1-7. 10.1002/mrm.25236.
6. Bizzi A., Brooks R.A., Brunetti A., Hill J.M., Alger J.R., Miletich R.S., Francavilla T.L., Di Chiro G. Role of iron and ferritin in MR imaging of the brain: a study in primates at different field strengths. Radiology 1990, 177:59-65.
7. Chen J.C., Hardy P.A., Kucharczyk W., Clauberg M., Joshi J.G., Vourlas A., Dhar M., Henkelman R.M. MR of human postmortem brain tissue: correlative study between T2 and assays of iron and ferritin in Parkinson and Huntington disease. AJNR Am. J. Neuroradiol. 1993, 14:275-281.
8. Cherubini A., Péran P., Caltagirone C., Sabatini U., Spalletta G. Aging of subcortical nuclei: microstructural, mineralization and atrophy modifications measured in vivo using MRI. Neuroimage 2009, 48:29-36. 10.1016/j.neuroimage.2009.06.035.
9. Dawe R.J., Bennett D.A., Schneider J.A., Vasireddi S.K., Arfanakis K. Postmortem MRI of human brain hemispheres: T2 relaxation times during formaldehyde fixation. Magn. Reson. Med. 2009, 61:810-818. 10.1002/mrm.21909.
10. De Rochefort L., Liu T., Kressler B., Liu J., Spincemaille P., Lebon V., Wu J., Wang Y. Quantitative susceptibility map reconstruction from MR phase data using bayesian regularization: validation and application to brain imaging. Magn. Reson. Med. 2010, 63:194-206. 10.1002/mrm.22187.
11. Dexter D.T., Carayon A., Javoy-Agid F., Agid Y., Wells F.R., Daniel S.E., Lees A.J., Jenner P., Marsden C.D. Alterations in the levels of iron, ferritin and other trace metals in Parkinson's disease and other neurodegenerative diseases affecting the basal ganglia. Brain 1991, 114(Pt 4):1953-1975. 10.1093/brain/114.4.1953.
12. Drayer B., Burger P., Darwin R., Riederer S., Herfkens R., Johnson G.A. MRI of brain iron. AJR Am. J. Roentgenol. 1986, 10.2214/ajr.147.1.103.
13. Duyn J.H., van Gelderen P., Li T.-Q., de Zwart J.A., Koretsky A.P., Fukunaga M. High-field MRI of brain cortical substructure based on signal phase. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:11796-11801. 10.1073/pnas.0610821104.
14. Gelman N., Gorell J.M., Barker P.B., Savage R.M., Spickler E.M., Windham J.P., Knight R.A. MR imaging of human brain at 3.0T: preliminary report on transverse relaxation rates and relation to estimated iron content. Radiology 1999, 210:759-767. 10.1148/radiology.210.3.r99fe41759.
15. Haacke E.M., Xu Y., Cheng Y.-C.N., Reichenbach J.R. Susceptibility weighted imaging (SWI). Magn. Reson. Med. 2004, 52:612-618. 10.1002/mrm.20198.
16. Haacke E.M., Cheng N.Y.C., House M.J., Liu Q., Neelavalli J., Ogg R.J., Khan A., Ayaz M., Kirsch W., Obenaus A. Imaging iron stores in the brain using magnetic resonance imaging. Magn. Reson. Imaging 2005, 23:1-25. 10.1016/j.mri.2004.10.001.
17. Haacke E.M., Ayaz M., Khan A., Manova E.S., Krishnamurthy B., Gollapalli L., Ciulla C., Kim I., Petersen F., Kirsch W. Establishing a baseline phase behavior in magnetic resonance imaging to determine normal vs. abnormal iron content in the brain. J. Magn. Reson. Imaging 2007, 26:256-264. 10.1002/jmri.20987.
18. Hallgren B., Sourander P. The effect of age on the non-haemin iron in the human brain. J. Neurochem. 1958, 3:41-51.
19. Jenkinson M. Fast, automated, N-dimensional phase-unwrapping algorithm. Magn. Reson. Med. 2003, 49:193-197. 10.1002/mrm.10354.
20. Khalil M., Langkammer C., Ropele S., Petrovic K., Wallner-Blazek M., Loitfelder M., Jehna M., Bachmaier G., Schmidt R., Enzinger C., Fuchs S., Fazekas F. Determinants of brain iron in multiple sclerosis: a quantitative 3T MRI study. Neurology 2011, 77:1691-1697. 10.1212/WNL.0b013e318236ef0e.
21. Kressler B., de Rochefort L., Liu T., Spincemaille P., Jiang Q., Wang Y. Nonlinear regularization for per voxel estimation of magnetic susceptibility distributions from MRI field maps. IEEE Trans. Med. Imaging 2010, 29:273-281. 10.1109/TMI.2009.2023787.
22. Langkammer C., Krebs N., Goessler W., Scheurer E., Ebner F., Yen K., Fazekas F., Ropele S. Quantitative MR imaging of brain iron: a postmortem validation study. Radiology 2010, 257:455-462. 10.1148/radiol.10100495.
23. Langkammer C., Schweser F., Krebs N., Deistung A., Goessler W., Scheurer E., Sommer K., Reishofer G., Yen K., Fazekas F., Ropele S., Reichenbach J.R. Quantitative susceptibility mapping (QSM) as a means to measure brain iron? A post mortem validation study. Neuroimage 2012, 62:1593-1599. 10.1016/j.neuroimage.2012.05.049.
24. Lebel R.M., Eissa A., Seres P., Blevins G., Wilman A.H. Quantitative high-field imaging of sub-cortical gray matter in multiple sclerosis. Mult. Scler. 2012, 18:433-441. 10.1177/1352458511428464.
25. LeVine S.M. Iron deposits in multiple sclerosis and Alzheimer's disease brains. Brain Res. 1997, 760:298-303. 10.1016/S0006-8993(97)00470-8.
26. Li L., Leigh J.S. Quantifying arbitrary magnetic susceptibility distributions with MR. Magn. Reson. Med. 2004, 51:1077-1082. 10.1002/mrm.20054.
27. Li T.Q., Yao B., van Gelderen P., Merkle H., Dodd S., Talagala L., Koretsky A.P., Duyn J. Characterization of T(2)* heterogeneity in human brain white matter. Magn. Reson. Med. 2009, 62:1652-1657. 10.1002/mrm.22156.
28. Li W., Wu B., Liu C. Quantitative susceptibility mapping of human brain reflects spatial variation in tissue composition. Neuroimage 2011, 55:1645-1656. 10.1016/j.neuroimage.2010.11.088.
29. Li W., Wu B., Batrachenko A. Differential developmental trajectories of magnetic susceptibility in human brain gray and white matter over the lifespan. Hum. Brain Mapp. 2014, 35:2698-2713. (Differential). 10.1002/hbm.22360.
30. Liu T., Spincemaille P., de Rochefort L., Kressler B., Wang Y. Calculation of susceptibility through multiple orientation sampling (COSMOS): a method for conditioning the inverse problem from measured magnetic field map to susceptibility source image in MRI. Magn. Reson. Med. 2009, 61:196-204. 10.1002/mrm.21828.
31. Liu T., Liu J., de Rochefort L., Spincemaille P., Khalidov I., Ledoux J.R., Wang Y. Morphology enabled dipole inversion (MEDI) from a single-angle acquisition: comparison with COSMOS in human brain imaging. Magn. Reson. Med. 2011, 66:777-783. 10.1002/mrm.22816.
32. Marques J.P., Maddage R., Mlynarik V., Gruetter R. On the origin of the MR image phase contrast: an in vivo MR microscopy study of the rat brain at 14.1T. Neuroimage 2009, 46:345-352. 10.1016/j.neuroimage.2009.02.023.
33. Meguro R., Asano Y., Odagiri S., Li C., Iwatsuki H., Shoumura K. Nonheme-iron histochemistry for light and electron microscopy: a historical, theoretical and technical review. Arch. Histol. Cytol. 2007, 70:1-19. 10.1679/aohc.70.1.
34. Mitsumori F., Watanabe H., Takaya N., Garwood M., Auerbach E.J., Michaeli S., Mangia S. Toward understanding transverse relaxation in human brain through its field dependence. Magn. Reson. Med. 2012, 68:947-953. 10.1002/mrm.23301.
35. Ogg R.J., Langston J.W., Haacke E.M., Steen R.G., Taylor J.S. The correlation between phase shifts in gradient-echo MR images and regional brain iron concentration. Magn. Reson. Imaging 1999, 17:1141-1148. 10.1016/S0730-725X(99)00017-X.
36. Peran P., Hagberg G., Luccichenti G., Cherubini A., Brainovich V., Celsis P., Caltagirone C., Sabatini U. Voxel-based analysis of R2* maps in the healthy human brain. J. Magn. Reson. Imaging 2007, 26:1413-1420. 10.1002/jmri.21204.
37. Rauscher A., Sedlacik J., Barth M., Mentzel H.-J., Reichenbach J.R. Magnetic susceptibility-weighted MR phase imaging of the human brain. AJNR Am. J. Neuroradiol. 2005, 26:736-742. (doi:26/4/736 [pii]).
38. Reichenbach J.R. The future of susceptibility contrast for assessment of anatomy and function. Neuroimage 2012, 62:1311-1315. 10.1016/j.neuroimage.2012.01.004.
39. Robinson S., Grabner G., Witoszynskyj S., Trattnig S. Combining phase images from multi-channel RF coils using 3D phase offset maps derived from a dual-echo scan. Magn. Reson. Med. 2011, 65:1638-1648. 10.1002/mrm.22753.
40. Schenck J.F., Zimmerman E.A. High-field magnetic resonance imaging of brain iron: birth of a biomarker?. NMR Biomed. 2004, 17:433-445. 10.1002/nbm.922.
41. Schweser F., Deistung A., Lehr B.W., Reichenbach J.R. Quantitative imaging of intrinsic magnetic tissue properties using MRI signal phase: an approach to in vivo brain iron metabolism?. Neuroimage 2011, 54:2789-2807. 10.1016/j.neuroimage.2010.10.070.
42. Shmueli K., de Zwart J.A., van Gelderen P., Li T.-Q., Dodd S.J., Duyn J.H. Magnetic susceptibility mapping of brain tissue in vivo using MRI phase data. Magn. Reson. Med. 2009, 62:1510-1522. 10.1002/mrm.22135.
43. Smith S.M. Fast robust automated brain extraction. Hum. Brain Mapp. 2002, 17:143-155. 10.1002/hbm.10062.
44. Stephenson E., Nathoo N., Mahjoub Y., Dunn J.F., Yong V.W. Iron in multiple sclerosis: roles in neurodegeneration and repair. Nat. Rev. Neurol. 2014, 10.1038/nrneurol.2014.118.
45. Sun H., Wilman A.H. Background field removal using spherical mean value filtering and Tikhonov regularization. Magn. Reson. Med. 2013, 1157:1151-1157. 10.1002/mrm.24765.
46. Thomas L.O., Boyko O.B., Anthony D.C., Burger P.C. MR detection of brain iron. AJNR Am. J. Neuroradiol. 1993, 14:1043-1048.
47. Van Duijn S., Nabuurs R.J.A., van Rooden S., Maat-Schieman M.L.C., van Duinen S.G., van Buchem M.A., van der Weerd L., Natté R. MRI artifacts in human brain tissue after prolonged formalin storage. Magn. Reson. Med. 2011, 65:1750-1758. 10.1002/mrm.22758.
48. Walsh A.J., Lebel R.M., Eissa A., Blevins G., Catz I., Lu J.-Q., Resch L., Johnson E.S., Emery D.J., Warren K.G., Wilman A.H. Multiple sclerosis: validation of MR imaging for quantification and detection of iron. Radiology 2013, 267:531-542. 10.1148/radiol.12120863.
49. Wharton S., Bowtell R. Whole-brain susceptibility mapping at high field: a comparison of multiple- and single-orientation methods. Neuroimage 2010, 53:515-525. 10.1016/j.neuroimage.2010.06.070.
50. Williams R., Buchheit C.L., Berman N.E.J., LeVine S.M. Pathogenic implications of iron accumulation in multiple sclerosis. J. Neurochem. 2012, 120:7-25. 10.1111/j.1471-4159.2011.07536.x.
51. Wu B., Li W., Guidon A., Liu C. Whole brain susceptibility mapping using compressed sensing. Magn. Reson. Med. 2012, 67:137-147. 10.1002/mrm.23000.
52. Yao B., Li T., Gelderen P.Van, Shmueli K., de Zwart J.A., Duyn J.H. Susceptibility contrast in high field MRI of human brain as a function of tissue iron content. Neuroimage 2009, 44:1259-1266. 10.1016/j.neuroimage.2008.10.029.
53. Zhang Y., Zabad R.K., Wei X., Metz L.M., Hill M.D., Mitchell J.R. Deep grey matter "black T2" on 3 tesla magnetic resonance imaging correlates with disability in multiple sclerosis. Mult. Scler. (Houndmills, Basingstoke, England) 2007, 10.1177/1352458507076411.
54. Zheng W., Nichol H., Liu S., Cheng Y.-C.N., Haacke E.M. Measuring iron in the brain using quantitative susceptibility mapping and X-ray fluorescence imaging. Neuroimage 2013, 78:68-74. 10.1016/j.neuroimage.2013.04.022.